Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura

Author： Gutterman L.A.   Kloster B.   Tsai H-M.  

Publisher： Academic Press

ISSN： 1079-9796

Source： Blood Cells, Molecules, and Diseases, Vol.28, Iss.3, 2002-03, pp. : 385-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange

By Basquiera A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 321-323

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab

By Chemnitz Jens   Uener Jens   Hallek Michael   Scheid Christof  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite

Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine

By Chamouni P.   Lenain P.   Buchonnet G.   Merle V.   Bourgain C.   Boyer A.   Girault C.   Czernichow P.  

Transfusion Science, Vol. 23, Iss. 2, 2000-10 ,pp. : 101-106

Elsevier

Access to resources Recommend Favorite

Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine

By Chamouni P.   Lenain P.   Buchonnet G.   Merle V.   Bourgain C.   Boyer A.   Girault C.   Czernichow P.  

Transfusion and Apheresis Science, Vol. 23, Iss. 2, 2000-10 ,pp. : 101-106

Elsevier

Access to resources Recommend Favorite

Macular infarction in thrombotic thrombocytopenic purpura

By Feiner Michael   Odeh Majed   Oliven Arie   Friedman Zvi  

Ocular Immunology and Inflammation, Vol. 9, Iss. 4, 2001-12 ,pp. : 273-275

Informa Healthcare

Access to resources Recommend Favorite